Mar 22, 2022 / 09:30AM GMT
Peter Jonathan Butterfield - Alliance Pharma plc - CEO & Executive Director
Okay. Good morning, everybody, and welcome to the Alliance 2021 Preliminary Results Presentation. I'm delighted to see so many of you here in person and look forward to meeting those of you who are listening on the webcast in the near future. I'm joined, as always, this morning by Andrew Franklin, our CFO. And I'd also like to take this opportunity to welcome Cora McCallum, who I know is familiar to many of you. Cora joins Alliance as Head of Investor Relations and Corporate Communications. Welcome, Cora.
So turning our attention to today's presentation. I'll begin with a reminder of our strategy and how this has supported our excellent performance in 2021 before handing over to Andrew to walk you through the detail of the results. I'll then finish with a summary and outlook for 2022 before opening the floor to questions.
This slide serves as a reminder of our strategy. We're committed to delivering solid organic growth through investment in marketing excellence supported by innovation and development. We
Preliminary 2021 Alliance Pharma PLC Earnings Call Transcript
Mar 22, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers